Tag: Viruses

Posted on

From Science Fair to Science Lab: Q&A With Chelsey Spriggs

by
0 comments
A headshot of Dr. Spriggs.
Credit: Courtesy of Dr. Chelsey Spriggs.

“It’s a thrill to make a discovery in science. In that moment, you’re the only one who knows about this new finding. Then you get to share that discovery with the world,” says Chelsey Spriggs, Ph.D. Dr. Spriggs is an assistant professor of cell and developmental biology at the University of Michigan (UMich) in Ann Arbor. We spoke with Dr. Spriggs about her early introduction to science through school science fairs, current research on viruses, and efforts to broaden participation in microbiology research across the world.

Get to Know Dr. Spriggs

  • Books or movies? Books
  • Coffee or tea? Coffee
  • Favorite music genre? R&B (’90s and ’00s)
  • Cats or dogs? Guinea pigs
  • Early bird or night owl? Early bird
  • Childhood dream job? Veterinarian
  • Favorite hobby? Painting
  • Favorite pipette size? 200uL
  • Favorite lab tool? Confocal microscope
Continue reading “From Science Fair to Science Lab: Q&A With Chelsey Spriggs”
Posted on

Investigating the Secrets of Cancer-Causing Viruses

by
0 comments
A portrait of Dr. Mandy Muller.
Credit: Courtesy of Dr. Mandy Muller.

While she was in graduate school, Mandy Muller, Ph.D., became intrigued with viruses that are oncogenic, meaning they can cause cancer. At the time, she was researching human papillomaviruses (HPVs), which can lead to cervical and throat cancer, among other types. Now, as an assistant professor of microbiology at the University of Massachusetts (UMass) Amherst, Dr. Muller studies Kaposi sarcoma-associated herpesvirus (KSHV), which causes the rare AIDS-associated cancer Kaposi sarcoma.

A Continental Change

Dr. Muller has come a long way, both geographically and professionally, since her childhood in France. She was the first person in her family to graduate from high school, where she excelled in science, and went on to attend École Normale Supérieure (ENS) de Lyon, a research-oriented undergraduate institution in Lyon, France. “We spent weeks at a time in laboratory-based classes, working in real labs. That’s when I realized people could do research full-time, which caught my attention,” says Dr. Muller. She double-majored in biology and geology, and soon chose to focus her career on immunology and virology.

Continue reading “Investigating the Secrets of Cancer-Causing Viruses”
Posted on

Quiz: Antibiotic Resistance and Researchers Studying It

by
0 comments

Antibiotics are a class of drugs that treat bacterial infections. They may seem common now, but they were discovered less than a century ago. In 1928, Alexander Fleming, a scientist studying bacteria, found that mold from his bread kept bacteria from growing. He determined that “mold juice” was able to kill different types of harmful bacteria, and he and his assistants worked to figure out what natural product in the mold was actually causing the killing. It turned out to be penicillin!

Thanks to Fleming’s discovery, doctors have been successfully treating bacterial infections with penicillin and other newer antibiotics. But in recent years, some infections that were once treatable with antibiotics no longer respond to them. Some of these infections can be treated with multiple rounds of different antibiotic treatments, but others aren’t treatable at all—even leading to death in some cases.

Continue reading “Quiz: Antibiotic Resistance and Researchers Studying It”
Posted on

Public Alerted to Omicron in New Mexico Through Quick Detection

by
0 comments
A sphere with spikes on the outside cut open to reveal a long strand.
Genetic material inside a virus. Credit: iStock.

Over the past 2 years, you’ve probably heard a lot about the spread of SARS-CoV-2—the virus that causes COVID-19—and the emergence of variants. The discovery and tracking of these variants is possible thanks to genomic surveillance, a technique that involves sequencing and analyzing the genomes of SARS-CoV-2 virus particles from many COVID-19 patients. Genomic surveillance has not only shed light on how SARS-CoV-2 has evolved and spread, but it has also helped public health officials decide when to introduce measures to help protect people.

In December 2021, the NIGMS-supported SARS-CoV-2 genomic surveillance program at the University of New Mexico Health Science Center (UNM HSC) in Albuquerque detected the first known case of the Omicron variant in the state, which enabled a rapid public health response. The program’s co-leaders, assistant professors Darrell Dinwiddie, Ph.D., and Daryl Domman, Ph.D., were watching on high alert for it to enter New Mexico, and when it did, they were poised to quickly identify it:

Continue reading “Public Alerted to Omicron in New Mexico Through Quick Detection”
Posted on

How Bacteria-Infecting Viruses Could Save Lives

by
0 comments
A headshot of Dr. Young.
Dr. Ry Young. Credit: Texas A&M University.

“My parents told me that I already wanted to be a scientist when I was 7 or 8 years old. I don’t remember ever considering anything else,” says Ry Young, Ph.D., a professor of biochemistry, biophysics, and biology at Texas A&M University, College Station.

Dr. Young has been a researcher for more than 45 years and is a leading expert on bacteriophages—viruses that infect bacteria. He and other scientists have shown that phages, as bacteriophages are often called, could help us fight bacteria that have developed resistance to antibiotics. Antibiotic-resistant infections cause more than 35,000 deaths per year in the U.S., and new, effective treatments for them are urgently needed.

Continue reading “How Bacteria-Infecting Viruses Could Save Lives”
Posted on

Through the Looking Glass: Microscopic Structures in Many Sizes

by
0 comments

We seldom see microscopic objects next to one another, so it can be difficult to picture how they compare. For instance, it might surprise you that a thousand cold-virus particles could line up across one human skin cell! The largest objects that scientists view through microscopes are about a millimeter (roughly the size of a poppyseed), and they’re about 10 million times larger than the smallest molecules scientists can view: atoms.

Continue reading “Through the Looking Glass: Microscopic Structures in Many Sizes”
Posted on

Pathways: The Superbug Issue

by
1 comment
Cover of Pathways student magazine showing blueish-green virus particles and text that reads, Stop the Spread of Superbugs (Yes, you can help!). Cover of Pathways student magazine.

NIGMS and Scholastic bring you our latest issue of Pathways, which focuses on superbugs—infectious microbes that can’t be fought off with medicines. Viruses that can’t be prevented with vaccines, such as the common cold, and antibiotic-resistant bacteria both fall into this category.

Pathways, designed for students in grades 6 through 12, is a collection of free resources that teaches students about basic science and its importance to health, as well as exciting research careers.

Continue reading “Pathways: The Superbug Issue”
Posted on

Shedding Light on Sepsis

by
1 comment

Sepsis is the body’s overactive and extreme response to an infection. It’s unpredictable, can progress rapidly, and affects more than 1.7 million people in the United States each year. Without prompt treatment, it can lead to tissue damage, organ failure, and death. NIGMS supports state-of-the-art sepsis research, including the development of rapid diagnostics and new therapeutics. September is Sepsis Awareness Month, and we’re highlighting a few resources that offer more information about this condition.

Our infographic provides details at a glance on basic statistics and the future of sepsis research. It’s also available in Spanish.

Continue reading “Shedding Light on Sepsis”
Posted on

Sepsis: Using Big Data to Cut a Killer Down to Size

by and
0 comments
A geographical outline of the U.S. with the text More than 1.7 million people get sepsis each year in the United States. View the full infographic for more facts about sepsis.

Sepsis is a serious medical condition caused by an overwhelming response to infection that damages tissues and organs. It’s unpredictable, progresses quickly, can strike anyone, and is a leading cause of hospital-related deaths. In the U.S. alone, nearly 270,000 people die each year from sepsis. Those who survive sepsis often end up in the hospital again, and some have long-term health complications. Early treatment is key for many patients to survive sepsis, yet doctors can’t easily diagnose it because it’s so complex and each patient is different.

Despite decades of research, sepsis remains a poorly understood condition with limited diagnostic tools and treatment. To tackle these obstacles, scientists Vincent Liu, Christopher Seymour, and Hallie Prescott have started using a “big data” approach, which relies on complex computer programs to sift through huge amounts of information. In this case, the computers analyze data such as demographic information, vital signs, and routine blood tests in the electronic health records of sepsis patients. The goal is to find patterns in the data that might help doctors understand, predict, and treat sepsis more effectively.

Continue reading “Sepsis: Using Big Data to Cut a Killer Down to Size”